Pharvaris Appoints Peng Lu, M.D., Ph.D., as Chief Medical Officer

Company strengthens executive team with addition of skilled HAE drug developer LEIDEN, Netherlands, Feb. 7, 2020 -- (Healthcare Sales & Marketing Network) -- Pharvaris B.V., a clinical-stage company focused on the discovery and development of novel ora... Biopharmaceuticals, Personnel Pharvaris, hereditary angioedema, angioedema
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news